Just a week after the first official data on the impact of Germany’s cannabis reforms was published, the Federal Cabinet
Germany’s booming cannabis market, which Prohibition Partners now estimates to be worth around €670m, is entering uncertain and potentially treacherous
German medical cannabis imports have continued their meteoric rise in the wake of the passage of its Cannabis Act (CanG), rising a further 15% on Q4, 2024 in the first quarter of 2025, totalling 37,223 kg.
Germany’s Federal Institute for Drugs and Medical Devices (BfArM) has published the medical cannabis import figures for Q2, giving us
Award-winning Frankfurt-based company Bloomwell Group GmbH (“Bloomwell Group”) today announced the launch of Germany’s largest centralised digital platform for medical
Germany’s highly anticipated CanG bill is now finally set to have its final reading in the Bundestag this week following
LVR University Hospital Essen, in collaboration with Algea Care, Europe’s leading telehealth platform for cannabis, has announced the results of
Germany’s CanG bill has been delayed yet again, just days after reports emerged that the coalition parties and Ministry of
Germany’s Ministry of Health has officially published its draft law for ‘Pillar 1’ of its plans to liberalise access to
GERMANY’S cannabis proposals have been met with a mixed response with many businesses seemingly frozen out of the cannabis club
DELAYS in submitting its proposals to the European Commission and potential hold-ups once submitted could see Germany’s adult-use cannabis plans
FURTHER details on Germany’s proposed adult-use cannabis market are to be published soon, and they will be avidly consumed with
We won’t spam you
